In prostate cancer, it was identified that downregulation of DAB2IP expression promotes resistance to ionizing radiation [15], initiates epithelial-to-mesenchymal transition [11] and drives tumor growth and metastasis [16]. This evidence concerns the gene DAB2IP and neoplasm.